Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33755163.
- Also identified by DOI 10.1001/jamanetworkopen.2021.2640 and PMC identifier 7988366.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study investigates the representation status of Black US residents in clinical trials of 24 cardiovascular drugs granted US Food and Drug Administration (FDA) approval between January 1, 2006, and August 31, 2020.
Medical subject headings
- Black or African American
- Cardiovascular Agents
- Cardiovascular Diseases
- Clinical Trials as Topic
- Drug Approval
- United States Food and Drug Administration